VAERS Explorer
Back to explore

Report #2832831

Received Mar 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
Feb 3, 2025
Onset
Feb 3, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK1965046—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No adverse side effects were reported.; GARDASIL 9 that was out of range, unmonitored for an unknown amount of time at unknown temperatures. Lot number was provided, expiration date was unknown. Administered 2/3/2025; This spontaneous report was received from a physician assistant concerning to a 43-year-old patient of unspecified gender. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On 03-Feb-2025, the patient was vaccinated with an improper stored dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), pre-filled syringe, lot #1965046, expiration date no provided but upon internal verification established as 22-Jan-2026, 1 dosage form (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis. The vaccine dose administered was out of range, unmonitored for an unknown amount of time at unknown temperatures (product storage error.) No adverse side effects were reported (no adverse event.) This was one of two reports received from the same reporter.